Table of Contents

Advances in Brief

• Advances in Brief

  A Public Database for Gene Expression in Human Cancers

  Anita Lal, Alex E. Lash, Stephen F. Altschul, Victor Velculescu, Lin Zhang, Roger E. McLendon, Marco A. Marra, Christa Prange, Patrice J. Morin, Kornelia Polyak, Nickolas Papadopoulos, Bert Vogelstein, Kenneth W. Kinzler, Robert L. Strausberg and Gregory J. Riggins

  Cancer Res November 1 1999 59 (21) 5403-5407;

  
  
• Advances in Brief

  The Nuclear Pore Complex Protein Nup88 Is Overexpressed in Tumor Cells

  Nerea Martínez, Angel Alons, María Dolores Moragues, José Pontón and José Schneider

  Cancer Res November 1 1999 59 (21) 5408-5411;

  
  
• Advances in Brief

  Antiangiogenic Therapy Targeting the Tyrosine Kinase Receptor for Vascular Endothelial Growth Factor Receptor Inhibits the Growth of Colon Cancer Liver Metastasis and Induces Tumor and Endothelial Cell Apoptosis

  Raymond M. Shaheen, Darren W. Davis, Wenbiao Liu, Brian K. Zebrowski, Michael R. Wilson, Corazon D. Bucana, David J. McConkey, Gerald McMahon and Lee M. Ellis

  Cancer Res November 1 1999 59 (21) 5412-5416;

  
  
• Advances in Brief

  Characterization of a Duocarmycin-DNA Adduct-recognizing Protein in Cancer Cells

  Akira Asai, Keiichi Yano, Tamio Mizukami and Hirofumi Nakano

  Cancer Res November 1 1999 59 (21) 5417-5420;

  
  
• Advances in Brief

  Increased Expression of Estrogen Receptor β mRNA in Tamoxifen-resistant Breast Cancer Patients

  Valerie Speirs, Carmel Malone, David S. Walton, Michael J. Kerin and Stephen L. Atkin

  Cancer Res November 1 1999 59 (21) 5421-5424;

  
  
• Advances in Brief

  Expression of Wild-Type Estrogen Receptor β and Variant Isoforms in Human Breast Cancer

  Suzanne A. W. Fuqua, Rachel Schiff, Irma Parra, William E. Friedrichs, Jui-Lan Su, David D. McKee, Kimberly Slentz-Kesler, Linda B. Moore, Timothy M. Willson and John T. Moore

  Cancer Res November 1 1999 59 (21) 5425-5428;

  
  
• Advances in Brief

  Oligodeoxynucleotides Containing CpG Motifs Can Induce Rejection of a Neuroblastoma in Mice

  Antoine F. Carpentier, Lin Chen, Fabrice Maltonti and Jean-Yves Delattre

  Cancer Res November 1 1999 59 (21) 5429-5432;

  
  
• Advances in Brief

  Flavopiridol, a Protein Kinase Inhibitor, Down-Regulates Hypoxic Induction of Vascular Endothelial Growth Factor Expression in Human Monocytes

  Giovanni Melillo, Edward A. Sausville, Kiona Cloud, Tyler Lahusen, Luigi Varesio and Adrian M. Senderowicz

  Cancer Res November 1 1999 59 (21) 5433-5437;

  
  
• Advances in Brief

  Aberrant Methylation in Gastric Cancer Associated with the CpG Island Methylator Phenotype

  Minoru Toyota, Nita Ahuja, Hiromu Suzuki, Fumio Itoh, Mutsumi Ohe-Toyota, Kohzoh Imai, Stephen B. Baylin and Jean-Pierre J. Issa

  Cancer Res November 1 1999 59 (21) 5438-5442;

  
  
• Advances in Brief

  Predominant Expression of Alternative PAX3 and PAX7 Forms in Myogenic and Neural Tumor Cell Lines

  Frederic G. Barr, Julie C. Fitzgerald, Jill P. Ginsberg, Michelle L. Vanella, Richard J. Davis and Jeannette L. Bennicelli

  Cancer Res November 1 1999 59 (21) 5443-5448;

  
  
• Advances in Brief

  Frequent Loss of Imprinting of PEG1/MEST in Invasive Breast Cancer

  Inge S. Pedersen, Peter A. Dervan, Dennise Broderick, Michèele Harrison, Nicola Miller, Emma Delany, Donal O’Shea, Paul Costello, Alo McGoldrick, George Keating, Brendan Tobin, Tom Gorey and Amanda McCann

  Cancer Res November 1 1999 59 (21) 5449-5451;

  
  
• Advances in Brief

  Quantitative and Temporal Correlation between Circulating Cell-Free Epstein-Barr Virus DNA and Tumor Recurrence in Nasopharyngeal Carcinoma

  Y. M. Dennis Lo, Lisa Y. S. Chan, Anthony T. C. Chan, Sing-Fai Leung, Kwok-Wai Lo, Jun Zhang, Joseph C. K. Lee, N. Magnus Hjelm, Philip J. Johnson and Dolly P. Huang

  Cancer Res November 1 1999 59 (21) 5452-5455;

  
  
• Advances in Brief

  Lack of Involvement of Ataxia Telangiectasia Mutated (ATM) in Regulation of Nuclear Factor-κB (NF-κB) in Human Diploid Fibroblasts

  Brian P. Ashburner, Rodney E. Shackelford, Albert S. Baldwin Jr. and Richard S. Paules

  Cancer Res November 1 1999 59 (21) 5456-5460;

  
  
• Advances in Brief

  Apoptotic Conversion

  Alexandre de la Taille, Min-Wei Chen, Martin Burchardt, Dominique K. Chopin and Ralph Buttyan

  Cancer Res November 1 1999 59 (21) 5461-5463;

  
  
• Advances in Brief

  Combining Serial Analysis of Gene Expression and Array Technologies to Identify Genes Differentially Expressed in Breast Cancer

  Mariana Nacht, Anne T. Ferguson, Wen Zhang, Joseph M. Petroziello, Brian P. Cook, Yu Hong Gao, Sharon Maguire, Deborah Riley, George Coppola, Gregory M. Landes, Stephen L. Madden and Saraswati Sukumar

  Cancer Res November 1 1999 59 (21) 5464-5470;

  
  
• Advances in Brief

  Cryptic Epitopes on α-Fetoprotein Induce Spontaneous Immune Responses in Hepatocellular Carcinoma, Liver Cirrhosis, and Chronic Hepatitis Patients

  Roberto Bei, Alfredo Budillon, Maria Gabriella Reale, Gaetano Capuano, Domenico Pomponi, Gabriele Budillon, Luigi Frati and Raffaella Muraro

  Cancer Res November 1 1999 59 (21) 5471-5474;

  
  
• Advances in Brief

  Epidermal Growth Factor Promotes MDA-MB-231 Breast Cancer Cell Migration through a Phosphatidylinositol 3′-Kinase and Phospholipase C-dependent Mechanism

  John T. Price, Tony Tiganis, Anurag Agarwal, Daniel Djakiew and Erik W. Thompson

  Cancer Res November 1 1999 59 (21) 5475-5478;

  
  
• Advances in Brief

  The PTEN Lipid Phosphatase Domain Is Not Required to Inhibit Invasion of Glioma Cells

  Daniel Maier, Graham Jones, Xinwei Li, Axel H. Schönthal, Otmar Gratzl, Erwin G. Van Meir and Adrian Merlo

  Cancer Res November 1 1999 59 (21) 5479-5482;

  
  
• Advances in Brief

  Mitogen-activated Protein Kinase Kinase 4/Stress-activated Protein/Erk Kinase 1 (MKK4/SEK1), a Prostate Cancer Metastasis Suppressor Gene Encoded by Human Chromosome 17

  Barbara A. Yoshida, Zita Dubauskas, Marina A. Chekmareva, Thomas R. Christiano, Walter M. Stadler and Carrie W. Rinker-Schaeffer

  Cancer Res November 1 1999 59 (21) 5483-5487;

  
  
• Advances in Brief

  Tumorigenicity of Human Breast Cancer Is Associated with Loss of the Ca²⁺-activated Chloride Channel CLCA2

  Achim D. Gruber and Bendicht U. Pauli

  Cancer Res November 1 1999 59 (21) 5488-5491;

  
  
• Advances in Brief

  Geranylgeranylated RhoB Mediates Suppression of Human Tumor Cell Growth by Farnesyltransferase Inhibitors

  Wei Du and George C. Prendergast

  Cancer Res November 1 1999 59 (21) 5492-5496;